Close Menu

glioblastoma

NEW YORK (GenomeWeb) – A study published online today in Science Translational Medicine suggests the brain cancer glioblastoma multiforme (GBM) can shed cells that make their way into a patient's blood stream, arguing against the notion that the disease is mainly restricted to the centra

NEW YORK (GenomeWeb) – Israeli RNAi drug developer Silenseed has filed to go public in the US, looking to raise around $36.4 million to support the continued clinical development of its oncology pipeline and the implantable delivery system that enables it.

NEW YORK (GenomeWeb) — Cells that make up brain tumors are more heterogeneous than previously thought, according to a new single-cell transcriptomic analysis appearing in Science today.

In launching a new project to identify precision medicine approaches for glioblastoma patients, researchers at the New York Genome Center are anticipating "an absolute gusher" of information from the sequencing and RNA analysis they will perform on approximately 20 study particip

NEW YORK (GenomeWeb News) – Teva Pharmaceuticals will be the exclusive distributor of MDxHealth's tests for prostate cancer and glioblastoma in Israel under a deal announced today.

Researchers from George Mason University have completed an analysis of samples and data from the National Cancer Institute's Cancer Genome Atlas (TCGA) project that indicates that laser capture microdissection of tumor samples could improve proteomic analyses.

NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute and its partners Nemucore Medical Innovations and Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have received a $3 million grant to fund a personalized glioblastoma treatment study.

NEW YORK (GenomeWeb News) – Glioblastoma tumors essentially hide mutant EGFR in response to therapies targeting those mutations, a new study appearing in Science reported today.

A research team from Northwestern University this week published new data showing that a class of novel nanoparticle conjugates, which have been exclusively licensed to startup AuraSense Therapeutics, can be used to deliver cancer-fighting siRNAs into the brains of mice.

The National Comprehensive Cancer Network now supports MGMT methylation testing in elderly glioblastoma patients to assess the likelihood that they will benefit from temozolomide treatment. This may help spur adoption of MDxHealth's MGMT PredictMDx for Glioblastoma test.

Pages

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.